A decade-long legal battle between Zimmer Biomet,\xa0 the Department of Justice (DOJ),\xa0 and Securities and Exchange Commission (SEC) ended in a grand finale with a $30.5 million settlement. Allegations include violations of the U.S> Foreign Corrupt Practices Act (FCPA) and improprieties in Brazil and Mexico.